Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR), 50374 [2018-21702]
Download as PDF
<![CDATA[
50374
Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices
daltland on DSKBBV9HB2PROD with NOTICES
advertising, promotion, offering for sale,
or sale of any product or service, from
making any misrepresentation about the
existence, contents, validity, results,
conclusions, or interpretations of any
test, study, or other research, or that any
product or service is scientifically or
clinically proven to produce any
benefit.
• Part V of the order requires that
respondents, with regard to any human
clinical test or study upon which they
rely to substantiate any claim covered
by the order, must preserve all
underlying data and documents
generally accepted by experts in the
field as relevant to an assessment of the
test.
• Part VI of the order provides that
nothing in the order prohibits
respondents from making a
representation for any drug that is
approved in labeling for such drug
under any tentative final or final
monograph promulgated by the Food
and Drug Administration, or under any
new drug application approved by the
FDA.
Parts VII through XI are reporting and
compliance provisions. Part VII
mandates that respondents acknowledge
receipt of the order and, for 10 years,
distribute the order to certain employees
and agents and secure acknowledgments
from recipients of the order. Part VIII
requires that respondents submit
compliance reports to the FTC one year
after the order’s issuance and submit
additional reports when certain events
occur. Part IX requires that, for 10 years,
respondents create certain records and
retain them for at least 5 years. Part X
provides for the FTC’s continued
compliance monitoring of respondents’
activity during the order’s effective
dates. Part XI is a provision
‘‘sunsetting’’ the order after 20 years,
with certain exceptions.
The purpose of this analysis is to
facilitate public comment on the
proposed order. It is not intended to
constitute an official interpretation of
the complaint or order, or to modify in
any way the order’s terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2018–21749 Filed 10–4–18; 8:45 am]
BILLING CODE 6750–01–P
VerDate Sep<11>2014
17:11 Oct 04, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response, (BSC, OPHPR)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Office of Public Health Preparedness
and Response, (BSC, OPHPR). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates up to 80 people.
Public participants should pre-register
for the meeting as described below.
Members of the public that wish to
attend this meeting in person should
pre-register by submitting the following
information by email, facsimile, or
phone (see contact person for more
information) no later than 12:00 noon
(EDT) on Wednesday, October 22, 2018:
• Full Name
• Organizational Affiliation
• Complete Mailing Address
• Citizenship
• Phone Number or Email Address
The public is also welcome to listen
to the meeting via Adobe Connect. Preregistration is required by clicking the
links below.
WEB ID: October 29, 2018 (1500
Seats) https://adobeconnect.cdc.gov/
e7gc21b4wp1/event/registration.html.
WEB ID: October 30, 2018 (1500
Seats) https://adobeconnect.cdc.gov/
e5j7o9ulmi8/event/registration.html.
Dial in number: 888–603–9747;
Participant code: 3564724 (100 Seats).
DATES: The meeting will be held on
October 29, 2018, 10:00 a.m.–to 5:00
p.m., EDT and October 30, 2018, 8:30
a.m.–3:30 p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention (CDC), Global
Communications Center, Building 19,
Auditorium B3, 1600 Clifton Road NE,
Atlanta, Georgia 30329–4027.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop D–44,
Atlanta, Georgia 30329–4027,
Telephone: (404) 639–7450; Fax: (404)
471–8772; Email:
OPHPR.BSC.Questions@cdc.gov.
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Office of Public Health Preparedness
and Response (OPHPR), concerning
strategies and goals for the programs
and research within OPHPR, monitoring
the overall strategic direction and focus
of the OPHPR Divisions and Offices,
and administration and oversight of
peer review for OPHPR scientific
programs. For additional information
about the Board, please visit: https://
www.cdc.gov/phpr/science/
counselors.htm.
Matters to be Considered: The agenda
for day one of the meeting will include
discussions that will cover briefings and
BSC deliberation on the following
topics: Interval updates from the OPHPR
Director and OPHPR Divisions and
Offices; Presentation on Private Sector
and PH Emergency Preparedness &
Response Collaboration; and updates
from the Biological Agent Containment
working group.
Day two of the meeting will cover
briefings and BSC deliberation on the
following topics: Preparedness updates
from Liaison representatives; CDC’s
Public Health Data Strategy and Data
Preparedness initiatives; and updates on
Pandemic Flu Activities and Planning
Updates. Agenda items are subject to
change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–21702 Filed 10–4–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21702]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Public Health
Preparedness and Response, (BSC, OPHPR)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
Office of Public Health Preparedness and Response, (BSC, OPHPR). This
meeting is open to the public, limited only by the space available. The
meeting room accommodates up to 80 people. Public participants should
pre-register for the meeting as described below. Members of the public
that wish to attend this meeting in person should pre-register by
submitting the following information by email, facsimile, or phone (see
contact person for more information) no later than 12:00 noon (EDT) on
Wednesday, October 22, 2018:
Full Name
Organizational Affiliation
Complete Mailing Address
Citizenship
Phone Number or Email Address
The public is also welcome to listen to the meeting via Adobe
Connect. Pre-registration is required by clicking the links below.
WEB ID: October 29, 2018 (1500 Seats) https://adobeconnect.cdc.gov/e7gc21b4wp1/event/registration.html.
WEB ID: October 30, 2018 (1500 Seats) https://adobeconnect.cdc.gov/e5j7o9ulmi8/event/registration.html.
Dial in number: 888-603-9747; Participant code: 3564724 (100
Seats).
DATES: The meeting will be held on October 29, 2018, 10:00 a.m.-to 5:00
p.m., EDT and October 30, 2018, 8:30 a.m.-3:30 p.m., EDT.
ADDRESSES: Centers for Disease Control and Prevention (CDC), Global
Communications Center, Building 19, Auditorium B3, 1600 Clifton Road
NE, Atlanta, Georgia 30329-4027.
FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and
Public Health Practice, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop D-44, Atlanta, Georgia 30329-4027,
Telephone: (404) 639-7450; Fax: (404) 471-8772; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Board is charged with providing advice and guidance
to the Secretary, Department of Health and Human Services (HHS), the
Assistant Secretary for Health (ASH), the Director, Centers for Disease
Control and Prevention (CDC), and the Director, Office of Public Health
Preparedness and Response (OPHPR), concerning strategies and goals for
the programs and research within OPHPR, monitoring the overall
strategic direction and focus of the OPHPR Divisions and Offices, and
administration and oversight of peer review for OPHPR scientific
programs. For additional information about the Board, please visit:
https://www.cdc.gov/phpr/science/counselors.htm.
Matters to be Considered: The agenda for day one of the meeting
will include discussions that will cover briefings and BSC deliberation
on the following topics: Interval updates from the OPHPR Director and
OPHPR Divisions and Offices; Presentation on Private Sector and PH
Emergency Preparedness & Response Collaboration; and updates from the
Biological Agent Containment working group.
Day two of the meeting will cover briefings and BSC deliberation on
the following topics: Preparedness updates from Liaison
representatives; CDC's Public Health Data Strategy and Data
Preparedness initiatives; and updates on Pandemic Flu Activities and
Planning Updates. Agenda items are subject to change as priorities
dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-21702 Filed 10-4-18; 8:45 am]
BILLING CODE 4163-19-P
